Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Neurology|July 12, 2021
Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide RescueValeria Koska, Moritz Förster, Katja Brouzou, et al.
Annals of Neurology|July 10, 2013
Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiationDavid Kremer, Tanja Schichel, Moritz Förster, et al.
Biomedicines|December 24, 2021
Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-AnalysisMoritz Förster, Christopher Nelke, Saskia Räuber, et al.
Microbes and Infection|November 22, 2024
HERV-W envelope protein is present in microglial cells of the human glioma tumor microenvironment and differentially modulates neoplastic cell behaviorLaura Reiche, Benedikt Plaack, Maike Lehmkuhl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
Oligodendroglial maturation is dependent on intracellular protein shuttlingPeter Göttle, Jennifer K Sabo, André Heinen, et al.
Brain Stimulation|February 19, 2022
The degree of cortical plasticity correlates with cognitive performance in patients with Multiple SclerosisCarolin Balloff, Iris-Katharina Penner, Meng Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosisDavid Kremer, Joel Gruchot, Vivien Weyers, et al.
International Journal of Molecular Sciences|June 24, 2020
Secretome Analysis of Mesenchymal Stem Cell Factors Fostering Oligodendroglial Differentiation of Neural Stem Cells In VivoIria Samper Agrelo, Jessica Schira-Heinen, Felix Beyer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2021
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension studyHans-Peter Hartung, Tobias Derfuss, Bruce Ac Cree, et al.
Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.
Pageof 6